Introduction: Lung cancer screening is underutilized, especially in rural areas where lung cancer mortality is high. Approximately 11.2% of the United States (US) population over age 50 meet the United States Preventive Services Task Force (USPSTF) 2021 lung cancer screening eligibility criteria; the proportion of eligible Veterans is unknown. This study evaluated the proportion of Veterans who are USPSTF-eligible and tested the hypothesis that more USPSTF-2021-eligible Veterans reside in rural versus non-rural areas.
Methods: Investigators cross-sectionally surveyed a national sample of Veterans age 50 years and older January-November 2022. Oversampling ensured inclusion of minority groups and accounted for geographic variation in tobacco use. Analyses in 2023-2024 evaluated the proportion of USPSTF-eligible Veterans by year (2013 and 2021) and tested USPSTF-2021 eligibility by rural status (rural vs non-rural) using Chi square tests. Weighting accounted for survey non-response and applied results to the whole Veteran population in a sensitivity analysis.
Results: Of 2,000 surveyed, 754 responded (37.7% response rate); most respondents were White (74.4%), male (92.6%), resided in non-rural areas (66.0%). Proportions meeting USPSTF criteria were 35.5% (95% CI 31.6-39.6%) in 2021 and 27.8% (95%CI 24.3-31.7%) in 2013. The proportion of USPSTF-2021-eligible rural Veterans (41.2%;95%CI 34.8-48.0%) was higher compared with non-rural (32.5%;95% CI 27.7-37.7%), P=0.037. A sensitivity analysis found the proportion of Veterans USPSTF-2021-eligible in the whole population was 33.0%.
Conclusions: The proportion of Veterans USPSTF-2021-eligible was nearly three times higher than the general US population (11.2%), and a greater proportion of eligible Veterans resided in rural compared with non-rural areas. These findings are critical for policies aimed at fully implementing lung cancer screening at scale.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.amepre.2025.01.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of educational interventions for community pharmacists on promoting human papillomavirus vaccination: A randomized double-blind parallel group comparison trial.
Vaccine X
January 2025
Shinagawa Pharmaceutical Association, 2-4-2 Nakanobu, Shinagawa-ku, Tokyo 142-0053, Japan.
Objective: Owing to persistent concerns about side effects, human papillomavirus (HPV) vaccination rates in Japan have remained low. Pharmacists are therefore encouraged to improve vaccination rates by providing accurate information. This study evaluated the impact of educational interventions on pharmacists' knowledge and willingness to recommend the HPV vaccine.
View Article and Find Full Text PDFFirst-line treatment for advanced or metastatic EGFR mutation-positive non-squamous non-small cell lung cancer: a network meta-analysis.
Front Oncol
January 2025
Department of Oncology, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Background: Several head-to-head meta-analyses have compared the efficacy and safety of different first-line treatments in patients with EGFR mutation-positive (M+) advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC). However, there is a lack of comprehensive evaluation encompassing multiple treatment strategies. Our objective is to conduct a network meta-analysis that includes various treatment modalities, enabling both direct and indirect comparisons for a more thorough assessment.
View Article and Find Full Text PDFBackground: Rearranged during transfection () fusions represent a distinct molecular subset of non-small cell lung cancer (NSCLC) with targeted therapeutic potential. Selpercatinib, a highly selective inhibitor, has demonstrated efficacy in various solid tumors harboring alterations. Here, we present a case highlighting the use and clinical outcomes of selpercatinib in a patient diagnosed with advanced lung adenocarcinoma harboring a fusion.
View Article and Find Full Text PDFEmerging from a PleurX Draining Catheter: An Unexpected Diagnosis.
Clin Med Insights Case Rep
January 2025
Infectious Disease Unit, Augusta Victoria Hospital, East Jerusalem, Palestine.
Introduction: is a common helminthic infection characterized by fecal-oral route of transmission. Commonly, it affects the gastrointestinal tract. However, in significantly rare cases, it can affect unexpected body regions, such as biliary tree, pancreas, and the lung.
View Article and Find Full Text PDFSelf-reported dyspnea and interest in a respiratory muscle training program among callers to the New York State Quitline.
Tob Induc Dis
January 2025
Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, United States.
Introduction: Cigarette smoking is an important risk factor in the development of dyspnea. Programs designed to strengthen the respiratory muscles can improve dyspnea in people with or without lung disease. As a first step in understanding the feasibility of offering a respiratory muscle training (RMT) program to people who are seeking help to try to quit smoking, we asked callers who contacted the New York State Quitline about their dyspnea and potential interest in a home-based RMT program.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!